B型主动脉夹层胸主动脉腔内修复术的成本分析:质量需要多少费用?
本文为叙述性综述,通过检索多个数据库概述了无并发症B型主动脉夹层中优化药物治疗与胸主动脉腔内修复术(TEVAR)、复杂B型主动脉夹层中TEVAR与开放手术修复的成本分析比较,并对市售TEVAR装置进行了市场分析。
要点
- 全球市场TEVAR装置价格为12000至19495美元。
- Terumo Aortic RELAY®支架移植物似乎最具成本效益并产生高度有利的临床结果。
- 文献证据强烈提示TEVAR长期优于优化药物治疗用于无并发症B型主动脉夹层。
核心结论
- TEVAR的出现通过为B型主动脉夹层提供高效且长期成本效益的治疗,彻底改变了大血管外科领域。
研究设计与样本
- 叙述性综述,使用PubMed、Ovid、Google Scholar、Scopus和Embase进行全面文献检索以识别和提取相关研究。
主要发现
- 市售TEVAR装置价格为12000至19495美元。
- Terumo Aortic RELAY®支架移植物似乎最具成本效益,产生高度有利的临床结果。
- 尽管TEVAR初始成本较高,文献证据强烈提示其长期优于优化药物治疗用于无并发症B型主动脉夹层。
- TEVAR在文献中被确立为复杂B型主动脉夹层的金标准修复技术,通过更低成本和改善结果提供更优的成本效益特征,取代开放手术修复。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aortic dissection (AD) is a life-threatening medical emergency that affects an estimated 3-4 people per 100,000 annually, with 40% of cases classified as type B AD (TBAD). TBAD can be further classified as being complicated (co-TBAD) or uncomplicated (un-TBAD) based on the presence or absence of certain features such as malperfusion and rupture. TBAD can be managed conservatively with optimal medical therapy (OMT), or invasively with open surgical repair (OSR) or thoracic endovascular aortic repair (TEVAR), depending on several factors such as type of TBAD and its clinical acuity. The cost-effectiveness, or cost-benefit profile, of these strategies must be given equal consideration. However, TBAD studies featuring cost analyses are limited within the literature. This narrative review aims to address the gap in the literature on cost-effectiveness of TBAD treatments by providing an overview of cost analyses comparing OMT with TEVAR in un-TBAD and TEVAR with OSR in co-TBAD. Another aim is to provide a market analysis of the commercially available TEVAR devices. METHODS: A comprehensive literature search was performed using several search engines including PubMed, Ovid, Google Scholar, Scopus, and Embase to identify and extract relevant studies. RESULTS: Several TEVAR devices are available commercially on the global market costing $12,000-19,495. Nevertheless, the Terumo Aortic RELAY® stent graft seems to be the most cost-effective, yielding highly favourable clinical outcomes. Despite the higher initial cost of TEVAR, evidence in the literature strongly suggest that it is superior to OMT for un-TBAD on the long-term. In addition, TEVAR is well established in the literature as being gold-standard repair technique for co-TBAD, replacing OSR by offering a more optimal cost-benefit profile through lower costs and improved results. CONCLUSIONS: The introduction of TEVAR has revolutionized the field of aortovascular surgery by offering a highly efficacious and long-term cost-effective treatment for TBAD.
引用
- Bashir M, Jubouri M, Patel R, et al. Cost Analysis of Thoracic Endovascular Aortic Repair in Type B Aortic Dissection: How Much Does Quality Cost? Ann Vasc Surg. 2022. PMID: 36306973. doi:10.1016/j.avsg.2022.09.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。